Can circulating interleukin-18 differentiate between sarcoidosis and idiopathic pulmonary fibrosis?

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 7, 2011, Pages 593-597

  Liu, Ding Hua ^a   Cui, Wei ^a   Chen, Qian ^a   Huang, Chun Mei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Blood; bronchoalveolar lavage fluid; idiopathic pulmonary fibrosis; interleukin 18; sarcoidosis

Indexed keywords

INTERLEUKIN 18;

ADULT; ARTICLE; B LYMPHOCYTE; CD4 CD8 RATIO; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; HUMAN; IMMUNE SYSTEM; LUNG FIBROSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; LUNG TUMOR; MALE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CD4-CD8 RATIO; CHINA; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTERLEUKIN-18; LUNG; LUNG NEOPLASMS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SARCOIDOSIS, PULMONARY; TUBERCULOSIS, PULMONARY;

EID: 80054055442     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.597871     Document Type: Article

References (17)

1. ATS/ERS/WASOG. Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
2. M üller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12:716-38. (Pubitemid 28420156)
3. Kunisawa A, Kawanishi Y, Tago H, Nagate A, Kasuga I, Ohyashiki K. Direct demonstration of the productive capability of cytokines at the single cell level in lung sarcoidosis using multicolor cytometry. Respiration 2002;69:155-64. (Pubitemid 34310131)
4. American Thoracic Society. Idiopathic pulmonary fi brosis: diagnosis and treatment; international consensus statement. Am J Respir Crit Care Med 2002;161:646-66.
5. Papiris SA, Kollintza A, Karatza M, Manali ED, Sotiropoulou C, Milic-Emili J, Roussos C, Daniil Z. CD8- T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fi brosis. J Infl amm (Lond) 2007;4:14-21.
6. Lukacs NW, Hogaboam C, Chensue SW, Blease K, Kunkel SL. Type 1/type 2 cytokine paradigm and the progression of pulmonary fi brosis. Chest 2001;120:5S - 8S. (Pubitemid 32702104)
7. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T. Cloning of a new cytokine that induces IFNgamma production by T cells. Nature 1995;378:88-91.
8. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999;162:5070-7.
9. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin- 18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001;19:423-74. (Pubitemid 32368042)
10. Liu DH, Yao YT, Cui W, Chen K. The association between interleukin-18 and pulmonary sarcoidosis: a meta-analysis. Scand J Clin Lab Invest 2010;70:428-32.
11. Kunkel SL, Lukacs NW, Strieter RM, Chensue SW. Th1 and Th2 responses regulate experimental lung granuloma development. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:120-8. (Pubitemid 26332088)
12. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-34. (Pubitemid 11047044)
13. American Thoracic Society/European Respiratory Society. International multidisciplinary consensus classi fi cation of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
14. Wallace WA, Ramage EA, Lamb D, Howie SE. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fi brosing alveolitis (CFA). Clin Exp Immunol 1995;101:436-41.
15. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-34. (Pubitemid 27183653)
16. Welker L, J ör res RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004;24:1000-6. (Pubitemid 39642292)
17. Yao Q, Xu ZJ, Huang H, Tian XL, Liu HR, Xu WB, Chen Y, Zhu YJ, Luo WC. Predictive value of single and combined indexes in the diagnosis of sarcoidosis. Chin J Tuberc Respir Dis 2008;31:488-91.